Literature DB >> 20185963

HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer.

Yukiko Moriwaka1, Yi Luo, Hitoshi Ohmori, Kiyomu Fujii, Naokuni Tatsumoto, Tomonori Sasahira, Hiroki Kuniyasu.   

Abstract

BACKGROUND: Cancer-secreted high mobility group 1 (HMGB1) induces apoptosis of macrophages and suppresses the host anti-cancer immune system.
OBJECTIVE: We here examined the effect of HMGB1 on macrophages in the lymph nodes of colorectal cancer (CRC) patients.
METHODS: Regional lymph nodes of 50 Dukes C CRCs were compared with 50 Dukes B CRCs.
RESULTS: Dukes C tumors exhibited higher HMGB1 labeling indices and higher HMGB1 concentrations in primary tumors than Dukes B CRCs. Macrophages in the regional lymph nodes were decreased in non-metastasized nodes as well as metastasized nodes in Dukes C cases, whereas macrophage numbers in Dukes B nodes were higher than in Dukes C nodes. Nodal HMGB1 concentration was higher in Dukes C nodes than in Dukes B nodes, being inversely correlated with macrophage numbers. Nodal HMGB1 concentration was correlated with HMGB1 concentration and lymph vessel density in the primary tumors.
CONCLUSION: These data suggest that HMGB1 secreted from primary tumors spread to the regional lymph nodes decreases the number of macrophages to attenuate the anti-metastatic defense of the lymph nodes in patients with CRCs. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185963     DOI: 10.1159/000272950

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  15 in total

1.  HMGB1 promotes lymphangiogenesis of human lymphatic endothelial cells in vitro.

Authors:  Yuanyuan Qiu; Ying Chen; Xin Fu; Lei Zhang; Jing Tian; Quan Hao
Journal:  Med Oncol       Date:  2010-12-22       Impact factor: 3.064

2.  Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells.

Authors:  Jing Zhang; Cang Liu; Ruiguang Hou
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

3.  The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Chen Chuangui; Tang Peng; Yu Zhentao
Journal:  Pathol Oncol Res       Date:  2012-04-29       Impact factor: 3.201

4.  High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.

Authors:  Yun-Fei Xu; Fu-Jun Ge; Bo Han; Xiao-Qing Yang; Hong Su; An-Cheng Zhao; Ming-Hong Zhao; Yu-Bao Yang; Jie Yang
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

5.  MiR-216b functions as a tumor suppressor by targeting HMGB1-mediated JAK2/STAT3 signaling way in colorectal cancer.

Authors:  Xiaoxiang Chen; Xiangxiang Liu; Bangshun He; Yuqin Pan; Huiling Sun; Tao Xu; Xiuxiu Hu; Shukui Wang
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

7.  Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas.

Authors:  Guoqiang Bao; Qing Qiao; Huadong Zhao; Xianli He
Journal:  World J Surg Oncol       Date:  2010-06-26       Impact factor: 2.754

8.  Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer.

Authors:  Rui-Qing Peng; Xiao-Jun Wu; Ya Ding; Chun-Yan Li; Xing-Juan Yu; Xing Zhang; Zhi-Zhong Pan; De-Sen Wan; Li-Ming Zheng; Yi-Xin Zeng; Xiao-Shi Zhang
Journal:  BMC Cancer       Date:  2010-09-16       Impact factor: 4.430

9.  Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.

Authors:  Kumiko Hongo; Shinsuke Kazama; Nelson H Tsuno; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  World J Surg Oncol       Date:  2015-01-27       Impact factor: 2.754

10.  The role of high mobility group box 1 (HMGB1) in colorectal cancer.

Authors:  Dinç Süren; Mustafa Yıldırım; Özlem Demirpençe; Vildan Kaya; Arsenal Sezgin Alikanoğlu; Nurullah Bülbüller; Mustafa Yıldız; Cem Sezer
Journal:  Med Sci Monit       Date:  2014-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.